Kolon Life Science Inc. (KOSDAQ:102940)
56,800
-3,800 (-6.27%)
Mar 9, 2026, 3:30 PM KST
Kolon Life Science Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 741,967 | 285,738 | 293,298 | 312,699 | 493,057 | 331,408 | Upgrade
|
| Market Cap Growth | 159.10% | -2.58% | -6.20% | -36.58% | 48.78% | 60.94% | Upgrade
|
| Enterprise Value | 856,767 | 384,979 | 380,259 | 385,923 | 578,014 | 375,012 | Upgrade
|
| Last Close Price | 56800.00 | 23000.00 | 25700.00 | 27400.00 | 43250.00 | 29050.00 | Upgrade
|
| PE Ratio | 44.01 | - | - | 146.58 | - | - | Upgrade
|
| Forward PE | - | 30.73 | 30.73 | 30.73 | 30.73 | 30.73 | Upgrade
|
| PS Ratio | 3.51 | 1.77 | 2.35 | 1.94 | 2.98 | 2.56 | Upgrade
|
| PB Ratio | 2.14 | 1.91 | 2.13 | 1.86 | 4.96 | 5.72 | Upgrade
|
| P/TBV Ratio | 2.15 | 1.92 | 2.13 | 1.88 | 5.03 | 5.86 | Upgrade
|
| P/OCF Ratio | 49.84 | - | - | - | - | - | Upgrade
|
| PEG Ratio | - | 94.42 | 94.42 | 94.42 | 94.42 | 94.42 | Upgrade
|
| EV/Sales Ratio | 4.06 | 2.38 | 3.05 | 2.39 | 3.49 | 2.90 | Upgrade
|
| EV/EBITDA Ratio | 31.91 | - | - | 31.87 | 37.17 | - | Upgrade
|
| EV/EBIT Ratio | 50.37 | - | - | 146.09 | 136.03 | - | Upgrade
|
| EV/FCF Ratio | -60.08 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.35 | 0.85 | 0.78 | 0.44 | 0.69 | 1.33 | Upgrade
|
| Debt / EBITDA Ratio | 4.56 | - | - | 6.10 | 4.43 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.33 | 0.76 | 0.73 | 0.40 | 0.41 | 1.07 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.28 | -8.64 | -6.57 | 5.58 | 2.64 | -4.84 | Upgrade
|
| Net Debt / FCF Ratio | -8.05 | -5.12 | -2.86 | -2.49 | -1.99 | -6.17 | Upgrade
|
| Asset Turnover | 0.43 | 0.44 | 0.40 | 0.59 | 0.69 | 0.49 | Upgrade
|
| Inventory Turnover | 3.08 | 2.53 | 1.65 | 2.18 | 2.89 | 2.81 | Upgrade
|
| Quick Ratio | 0.24 | 0.24 | 0.26 | 0.33 | 0.51 | 0.26 | Upgrade
|
| Current Ratio | 0.56 | 0.50 | 0.82 | 1.01 | 1.03 | 0.69 | Upgrade
|
| Return on Equity (ROE) | 7.75% | -64.87% | -22.00% | 3.01% | -1.75% | -54.34% | Upgrade
|
| Return on Assets (ROA) | 2.16% | -3.79% | -4.83% | 0.60% | 1.10% | -6.13% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.93% | -8.81% | -10.18% | 1.37% | 3.26% | -18.53% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.70% | -10.40% | -13.30% | 1.30% | 3.10% | -25.00% | Upgrade
|
| Earnings Yield | 2.40% | -32.58% | -10.48% | 0.68% | -0.28% | -13.03% | Upgrade
|
| FCF Yield | -1.92% | -7.80% | -11.94% | -8.69% | -4.18% | -3.03% | Upgrade
|
| Buyback Yield / Dilution | -18.03% | -4.65% | 9.69% | -10.85% | - | 0.01% | Upgrade
|
| Total Shareholder Return | -18.03% | -4.65% | 9.69% | -10.85% | - | 0.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.